PTJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


PHYS THER
Vol. 75, No. 6, June 1995, pp. 511-525

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moncur, C.
Right arrow Articles by Williams, H J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moncur, C.
Right arrow Articles by Williams, H J.
Related Collections
Right arrow Rheumatoid Arthritis
Right arrow Pharmacology
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Special Series: Pharmacology

Rheumatoid Arthritis: Status of Drug Therapies

Carolee Moncur and H James Williams

C Moncur, PhD, PT, is Professor and Co-Director, Division of Physical Therapy, College of Health, Adjunct Professor of Internal Medicine, Division of Rheumatology, Department of Internal Medicine, School of Medicine, and Adjunct Professor of Bioengineering, College of Mines and Engineering, University of Utah, Salt Lake City, UT 84112 (USA).
HJ Williams, MD, is Professor and Chief, Division of Rheumatology, Department of Internal Medicine, and Associate Chair, Department of Internal Medicine, School of Medicine, University of Utah.

This article describes the current drug therapies used to manage rheumatoid arthritis (RA). A brief description of the pathology, pathogenesis, and clinical features of RA is presented. The purpose of the article is to increase an awareness among physical therapists regarding the medications their patients might be taking and how these agents might influence the outcome of physical therapy intervention. The general approach to prescribing medication is presented according to the status of the disease. The attributes of nonsteroidal anti-inflammatory drugs, corticosteroids, slow-acting antirheumatic drugs, and cytotoxic and experimental drugs used in RA are described. Given the potential benefits, side effects, and adverse reactions of these potentially powerful medications, it is important for the physical therapist to monitor closely what is happening to the patient with respect to the use or nonuse of the medication.

Key Words: Drug therapy • Physical therapy • Rheumatoid arthritis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Physical Therapy Association.